Sanofi and partners’ success with repurposed antibodies for Covid-19 depend on recruiting less critically ill patients
Focus:
-
![covid-19 clinical trials]()
Mixed results from recently completed Covid-19 clinical trials
-
![Hydroxychloroquine trial]()
Hydroxychloroquine trial to begin enrolling Covid-19 hospitalised patients next week
-
![trial delays]()
Trial delays in the time of Covid-19
-
![Covid-19 pandemic clinical trials]()
The impact of the Covid-19 pandemic on clinical trials
-
![Figure 1: Top 5 COVID-19 Clinical Trials by Number of Subjects Planned. Credit: GlobalData.]()
Largest Covid-19 trials studying Umifenovir or traditional Chinese medicine
-
![Figure 1: Infectious Disease Clinical Trials in China by Status. Credit: GlobalData.]()
Overview of infectious disease clinical trials in China
Most Read
- Exploring efficiencies from eTMF with Cancer Research UK
- FDA accelerated review denial is a blow to Spectrum’s poziotinib
- New drugs and therapeutic options help the immune system fight cancer
- Roche’s Tecentriq threatens BMS’ Opdivo in small cell lung cancer market
- The challenges of using stem cells in neurology
Company A-Z
Latest Content
Defenvid, Biotechnological/Nutraceutical Product with Immune-Enhancing Properties
DefenVid is an innovative nutraceutical of the lipofishin family. E-JUR-94013TM is the structural base of DefenVid, a bioderivative obtained from the species Trachurus trachurus (Atlantic horse mackerel).
Unlocking the Power of Expert Analytics
Malvern Panalytical, with Concept Life Sciences (Cheshire, UK), has begun an innovative partnership that unites advanced instrumentation with proficient analytical services for discovery and development.
2020 Forthcoming Events
Below are the forthcoming shows that will exhibit Malvern’s pharmaceutical solutions.
Influenza drug favipiravir is being tested to treat Covid-19
Treatment options for Covid-19 are urgently needed as the total number of confirmed cases globally rises to 550,000 on Friday and the US becomes the country with the most confirmed cases, at over 86,000. One of the potentially quickest ways to find treatment is to test substances already approved or in development for other indications.
Battery Research and Quality Control Solutions
The age of the battery is well underway. Lithium-ion batteries, for example, have already revolutionized our day-to-day lives – from smart mobile devices to pollution-free electric cars and intelligent power management solutions.
Aurora trial reveals possible drug to treat Lupus kidney disease
Aurora, a Phase III global trial presented by the National Kidney Foundation (NKF), has revealed a possible drug for the treatment of lupus kidney disease.
Latest News
Close
Close
Close
Go Top